Company Overview
Company Type: Private Company
Company Status: Operating Subsidiary
Website: pancella.com
Number of Employees: -
Year Founded: 2015
Total Amount Raised (CAD mm)†: 1.00
Total Rounds of Funding**:1
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
panCELLa Inc. develops FailSafe cell therapy system for regulators, clinicians, and patients to make decisions for the treatment of degenerative and malignant diseases. The company was incorporated in 2015 and is based in Toronto, Canada. panCELLa Inc. operates as a subsidiary of Pluristyx, Inc.


Financial Information (Currency: CAD, in mm)
Total Revenue
-
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
-
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Rao, Mahendra S.
CEO & Director
Keating, Armand 
Scientific Founder & Director
Nagy, Andras 
Scientific Founder, Director & Chair Scientific Advisory Board
Schummer, Lisa 
Manager of Operations

Key Board Members
Name
Title
Krembil, Mark 
Chairman
Rao, Mahendra S.
CEO & Director
Keating, Armand 
Scientific Founder & Director
Nagy, Andras 
Scientific Founder, Director & Chair Scientific Advisory Board
Hood, Greg 
Member of the Scientific Advisory Board
May, Michael H.
Member of the Scientific Advisory Board
Scheel, Andreas 
Director


Primary Industry Classification
Biotechnology


Primary Office Location
661 University Avenue Suite 1300 | Toronto, ON | M5G 0B7 | Canada
Phone: 888-613-6862   

Parent Company
Pluristyx, Inc.

Prior Investors
CCRM Enterprises Inc., Chiefswood Holdings Limited


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Oct-06-2022
-
Merger/Acquisition
Target
panCELLa Inc.
Pluristyx, Inc.

-
Jan-24-2018
Jan-24-2018
Private Placement
Target
panCELLa Inc.
Chiefswood Holdings Limited

0.81
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Oct-06-2022
M&A Transaction Announcements
Pluristyx, Inc. entered into a definitive merger agreement to acquire panCELLa Inc.
Apr-19-2022
Company Conference Presentations
panCELLa Inc. Presents at Cell & Gene Meeting on the Mediterranean, Apr-19-2022
Oct-12-2021
Company Conference Presentations
panCELLa Inc. Presents at Cell & Gene Meeting on the Mesa, Oct-12-2021
Jan-08-2021
Business Expansions
panCELLa Inc. Accelerates Cell-Based Therapies by Providing Safe Therapeutic MSC Products
Oct-22-2020
Company Conference Presentations
panCELLa Inc. Presents at Cell & Gene Therapy Bioprocessing & Commercialization, Oct-22-2020 09:20 AM


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 14, 2023 09:22 PM
panCELLa Inc.
panCELLa Inc
Reports
39
GlobalData

Jun 15, 2023 11:28 PM
panCELLa Inc.
panCELLa Inc
Reports
39
GlobalData

Mar 16, 2023 05:00 AM
panCELLa Inc.
panCELLa Inc
Reports
38
GlobalData

Dec 14, 2022 06:34 PM
panCELLa Inc.
panCELLa Inc
Reports
37
GlobalData

Sep 16, 2022 09:32 PM
panCELLa Inc.
panCELLa Inc
Reports
34
GlobalData

Jun 15, 2022 04:01 AM
panCELLa Inc.
panCELLa Inc
Reports
34
GlobalData

Mar 13, 2022 02:46 AM
panCELLa Inc.
panCELLa Inc
Reports
33
Infinata, Inc.
Infinata Research
Oct 13, 2021 12:41 AM
panCELLa Inc.
Pancella Inc. - Company Report
Reports
8
Infinata, Inc.
Infinata Research
Sep 14, 2021 09:40 AM
panCELLa Inc.
Pancella Inc. - Company Report
Reports
8
Infinata, Inc.
Infinata Research
Jun 17, 2021 04:19 AM
panCELLa Inc.
Pancella Inc. - Company Report
Reports
8


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Key Board Members Details
Name
Title
Phone
Fax
Email
Krembil, Mark 
Chairman
416-861-8391X102
-

Rao, Mahendra S.
CEO & Director
888-613-6862
-

Keating, Armand 
Scientific Founder & Director
888-613-6862
-

Nagy, Andras 
Scientific Founder, Director & Chair Scientific Advisory Board
888-613-6862
-

Hood, Greg 
Member of the Scientific Advisory Board
888-613-6862
-

May, Michael H.
Member of the Scientific Advisory Board
888-613-6862
-

Scheel, Andreas 
Director
888-613-6862
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Rao, Mahendra S.
CEO & Director
888-613-6862
-

Keating, Armand 
Scientific Founder & Director
888-613-6862
-

Nagy, Andras 
Scientific Founder, Director & Chair Scientific Advisory Board
888-613-6862
-

Schummer, Lisa 
Manager of Operations
888-613-6862
-

* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
